InCarda Logo.png
InCarda Therapeutics Announces Execution of Planned CEO Transition to Drive Next Phase of Corporate Growth
04 oct. 2022 07h00 HE | InCarda Therapeutics, Inc.
Robert Lisicki Appointed as New Chief Executive Officer and Board Member; Possesses Broad Commercial and Public Company Experience Grace E, Colón, Ph.D., Stepping Aside Following Nearly Ten Years as...
Heart Tumor Market Size Worth USD 1.36 Billion by 2030 at 8.5% CAGR - Report by Market Research Future (MRFR)
29 sept. 2022 02h30 HE | Market Research Future
New York, USA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Heart Tumor Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Heart Tumor Market Information By...
Bio-Sig-Logo-horiz.jpg
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
22 sept. 2022 09h00 HE | BioSig Technologies, Inc.
Westport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
Introducing Fox & Muse: Integrating Dating, Security, and Luxury
08 sept. 2022 11h00 HE | Fox & Muse
AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- On the heels of Tinder Swindler, it's a commonly-known fact that the dating space is saturated with the likes of fakes, scammers, catfish, and...
researchdrivelogo.jpg
Global Wearable Cardiac Devices Market Predicted to Register $7,733.1 Million and Grow at 26.5% CAGR by 2027 Post Covid-19 Catastrophe | Research Dive
05 sept. 2022 09h00 HE | Research Dive
New York, USA, Sept. 05, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global wearable cardiac devices market is predicted to register a revenue of $7,733.1...
Bio-Sig-Logo-horiz.jpg
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
30 août 2022 09h37 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Company increases sales efforts and strategy, adds new National Account Executives to accelerate commercial growth Strengthens marketing team with...
Bio-Sig-Logo-horiz.jpg
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
24 août 2022 09h17 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Leading Medical Center of Excellence adds second PURE EP™ System for evaluation, broadening physician access to the Company’s signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022
17 août 2022 09h15 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Sees Positive Momentum from Sales Pipeline Growth
16 août 2022 09h47 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Company sees increase in medical centers entering into 60-day evaluation agreements Existing customers seeing positive results from PURE EP™ System...
Straits Research Pvt Ltd
Defibrillator Market Size is projected to reach USD 21 Billion by 2030, growing at a CAGR of 7.18%: Straits Research
03 août 2022 13h00 HE | Straits Research
New York, United States, Aug. 03, 2022 (GLOBE NEWSWIRE) -- A Defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances such ventricular fibrillation,...